No.	Topic	Speaker	Launching Date
1	Immunity and Inflammation in Chronic Hepatitis B in Adults – When to Treat?	Kyong-Mi Chang, MD	20th April,2015
2	Currently Approved Hepatitis B Therapeutics: Their Indications and Limitations	Brian J. McMahon, MD	20th April,2015
3	Does Combination Therapy of Interferon and Nucleoside Analogs Make Sense?	Marc G. Ghany, MD, MHSc	27th April,2015
4	Proof-of concept Phase 2a clinical trials in HBV and HBV HDV infected patients with the entry inhibitor Myrcludex	Stephan Urban, PhD	4th May,2015
5	Eradication of cccDNA by Small Molecules	Ju-Tao Guo, MD	11th May,2015
6	Assembly Inhibitors	Stephen Locarnini, MD, PhD	18th May,2015
7	Eradication of cccDNA by Immune Modulators	T. Jake Liang, MD	25th May,2015
8	Toll-like Receptor, PD1 and Other Immune Modulators	Fabien Zoulim, MD	1st June,2015
9	Therapeutic Vaccines, siRNA, Other Nucleic Acid-based Technologies	Kyong-Mi Chang, MD	8th June,2015
10	When Immune Surveillance Fails: Managing Hepatocellular Cancer	Tushar Patel, MBChB	27th April,2015
11	Emerging Trends in Hepatology Practice: Science Driven Care of Liver Diseases and Cancer- From Stem Cells to Genomics	Lopa Mishra, MD	27th April,2015
12	HCC Screening Update	Laura M. Kulik, MD	27th April,2015
13	Living Donor Liver Transplantation: Has it Fulfilled Its Promise?	Jean C. Emond, MD	27th April,2015
14	Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture	Jay H.Hoofnagle, MD	27th April,2015
15	Four Decades of Progress in Hepatology	Willis C. Maddrey, MD	27th April,2015